Received Jun 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | UNK | LP4947 | — |
red rash at site of injection/likely celulitis; red rash at site of injection/likely celulitis; This is a spontaneous report received from a Physician. A 67-year-old female patient (not pregnant) received pneumococcal 20-valent conjugated vaccine (diphtheria CRM197 protein) (PREVNAR 20), on 12Jun2025 as dose number unknown, single (Lot number: LP4947) for immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Penicillin, reaction(s): "Hypersensitivity"; Bactrim, reaction(s): "Hypersensitivity"; Tetracycline, reaction(s): "Hypersensitivity". The following information was reported: VACCINATION SITE CELLULITIS (non-serious), VACCINATION SITE RASH (non-serious) all with onset 13Jun2025, outcome "unknown" and all described as "red rash at site of injection/likely celulitis". Therapeutic measures were taken as a result of vaccination site cellulitis, vaccination site rash. Additional information: The patient did not receive any other vaccines on the same date as the vaccine(s) for which you are reporting. The patient did not receive any other vaccines within 4 weeks prior to the vaccine(s) for which you are reporting. The patient taking any other medications within 2 weeks of the event starting. Treatment received for the adverse event included antibiotic. Causality for "red rash at site of injection/likely celulitis" was determined associated to device constituent of pneumococcal 20-val conj vac (dipht CRM197 protein) (malfunction).